Phenotypic Characterization of Recently Identified PSEN1 Genetic Variants in ADAD in Colombia
These findings are consistent with existing literature and underscore the value of characterizing preclinical ADAD cohorts, supported by biomarkers, to guide early diagnostic and therapeutic strategies, especially in the context of clinical trials. We expect to have complete fluid and neuroimaging biomarker and follow-up data for the presentation of these results.
Authors
- Yamile Bocanegra (ORCID: https://orcid.org/0000-0003-3064-2509)
- Claudia Muñoz (ORCID: https://orcid.org/0000-0003-4961-5308)
- Laura Ramirez Aguilar
- Ana Baena (ORCID: https://orcid.org/0000-0002-5622-4519)
- Victoria Zubiri
- David Fernando Aguillon (ORCID: https://orcid.org/0000-0003-2283-536X)
- Laura Serna (ORCID: https://orcid.org/0000-0002-4705-3519)
- Cláudia Ramos (ORCID: https://orcid.org/0000-0002-0030-4501)
- Jorge J. Llibre‐Guerra (ORCID: https://orcid.org/0000-0002-2137-7750)
- Elkin Garcia‐Cifuentes
- Jan Karlo Rodas‐Marin
- Alejandro Guerrero
- Juan F Martínez
- Sindy Duque
- Yudy M Leon‐Varela
Institutions
- Washington University in St. Louis (US)
- Universidad de Antioquia (CO)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108984
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00